Exploring how genetic diversity affects muscular dystrophy treatments
Implications of Genetic Diversity in Muscular Dystrophy
This study is looking at how different genetic makeups affect muscular dystrophy to help create better, personalized treatments for people with the condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11065745 on NIH RePORTER |
What this research studies
This research investigates the impact of genetic diversity on muscular dystrophy (MD) to improve precision medicine approaches. By using a model that incorporates a range of genetic variations, the study aims to better simulate the diverse patient populations seen in real-world clinical settings. The goal is to develop more effective genetic therapies that account for individual differences in genetics, which could lead to improved treatment outcomes for patients with MD. The research will analyze how these genetic variations influence neuromuscular symptoms and responses to therapy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with muscular dystrophy who have diverse genetic backgrounds.
Not a fit: Patients with muscular dystrophy who do not have genetic variations relevant to the study may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatments for patients with muscular dystrophy.
How similar studies have performed: Other research has shown promise in using genetic diversity to enhance treatment approaches, but this specific method is innovative and largely untested.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Kemaladewi, Dwi Utami — University of Pittsburgh at Pittsburgh
- Study coordinator: Kemaladewi, Dwi Utami
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.